ImmuniWeb and GitLab offer solutions in cybersecurity and development platforms. ImmuniWeb has an advantage in pricing and support, while GitLab leads with comprehensive features.
Features: ImmuniWeb offers powerful threat detection, intuitive risk management, and strategic integrations. GitLab provides extensive CI/CD pipeline integration, collaborative tools, and a full suite of features for development teams seeking end-to-end solutions.
Room for Improvement: ImmuniWeb users suggest enhancements in reporting, expanding integration options, and refining strategic integrations. GitLab could improve performance speed, decrease system downtime, and enhance reliability.
Ease of Deployment and Customer Service: ImmuniWeb has straightforward deployment and responsive customer service. GitLab offers flexible deployment options but presents mixed reviews regarding customer service.
Pricing and ROI: ImmuniWeb is noted for strong ROI and cost-effective pricing. GitLab, despite higher costs, is valued for feature richness and productivity gains justifying the investment.
GitLab offers a secure and user-friendly platform for CI/CD pipeline management, code repository control, and collaboration, enhancing development speed and efficiency. It facilitates automation with extensive customization and tool integration, ideal for DevOps processes.
GitLab supports source code management, version control, and collaborative development. It's frequently used in CI/CD processes to automate builds and deployments while integrating DevOps practices. GitLab allows companies to manage repositories, automate pipelines, conduct code reviews, and maintain development lifecycles. The platform supports infrastructure and configuration management, enabling efficient code collaboration, deployment automation, and comprehensive repository handling. Many organizations commit and deploy developed code using GitLab's capabilities.
What are GitLab's most valuable features?In specific industries, GitLab serves as a backbone for source code management and CI/CD implementation. Companies leverage its capabilities for infrastructure management and deployment automation, thus streamlining project delivery timelines. Its ability to handle configuration management and code repositories effectively aids in maintaining development lifecycles, making it a preferred choice for organizations committed to enhancing their DevOps practices.
ImmuniWeb is a global application security company operating in over 50 countries, headquartered in Geneva, Switzerland. Most of ImmuniWeb's customers come from regulated industries, such as banking, healthcare, and e-commerce.
ImmuniWeb® AI Platform leverages award-winning AI and Machine Learning technology for acceleration and intelligent automation of Attack Surface Management and Dark Web Monitoring. The data is later leveraged for threat-aware and risk-based Application Penetration Testing for web, mobile, and API security testing. ImmuniWeb is the only company that offers a contractual zero false-positives SLA with a money-back guarantee. ImmuniWeb’s AI technology is a recipient of numerous awards and recognitions, including Gartner Cool Vendor, IDC Innovator, and the winner of “SC Award Europe” in the “Best Usage of Machine Learning and AI” category.
ImmuniWeb® Community Edition runs over 100,000 daily tests, being one of the largest application security communities. ImmuniWeb SA is an ISO 27001 certified and CREST-accredited company.
We monitor all Static Application Security Testing (SAST) reviews to prevent fraudulent reviews and keep review quality high. We do not post reviews by company employees or direct competitors. We validate each review for authenticity via cross-reference with LinkedIn, and personal follow-up with the reviewer when necessary.